World's first pediatric deformity case using immersive augmented reality surgical navigation

2023-12-21
SALT LAKE CITY, Dec. 21, 2023 /PRNewswire/ -- Dr. Scott Luhmann, an orthopedic surgeon at Washington University School of Medicine in St. Louis, performed the world's first pediatric deformity case using the VisAR immersive augmented reality surgical navigation. Ten pedicle screws were successfully placed during the surgery, which was conducted at St. Louis Children's Hospital on the Washington University Medical Campus.
Continue Reading
World's first pediatric deformity case using immersive augmented reality surgical navigation
Preview
来源: PRNewswire
Courtesy of EMC hospital
The immersive nature of VisAR enables greater accuracy during surgery with a shorter learning curve. Typically, surgeons need to look back and forth from a screen to the patient in order to use navigation software. With VisAR, 3D image datasets are superimposed on the patient's body, enabling the surgeon to look directly at the patient throughout the surgery using an augmented reality headset. The entire OR footprint is a small AR headset on the doctor's head, reducing clutter in operating rooms.
Dr. Wendell Gibby, CEO of Novarad who has used VisAR in many surgical environments, commented that "it is unique among navigation systems in that the image and patient registration are nearly instantaneous. For example, in a typical navigation system, if you deflect the spine, there is a lag before the images are re-registered. With VisAR, this lag is only 200 msec using the patented image visible optical trackers. This live, dynamic adjustment of the images allows the surgeon to proceed faster and with more confidence."
VisAR provides surgeons with a real-time, three-dimensional visualization of the surgical site, allowing for better depth perception and spatial awareness. It allows the surgeon to integrate preoperative imaging data (such as CT scans) directly into the field of view. This produces a personalized, patient-specific surgical plan, optimizing the approach and minimizing damage to surrounding healthy tissues.
VisAR is FDA cleared for stereotactic spinal surgery and is currently under review for stereotactic cranial surgery in the USA. Regulatory applications are pending in Europe, Philippines, Vietnam and other countries. Visar's predecessor Opensight was the first AR navigation system cleared for pre-operative use over 5 years ago and has similar CE mark status. VisAR has been used in eight countries for a wide variety of applications, including spinal implant guidance, plastic surgery, orthopedic trauma and oncology, and interventional radiology. Several clinical trials are currently underway for cranial surgery as well.
VisAR is available in the United States, Mexico, and Indonesia, with other countries expected to approve the technology in upcoming months. Visit novarad.net/visar for more information or to schedule a demonstration.
Novarad is a global healthcare technology company specializing in the development and deployment of innovative medical imaging and informatics solutions.
For more information about Novarad Corporation and its revolutionary VisAR augmented reality surgical navigation system, please visit novarad.net/
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。